Subthreshold Micropulse Laser Therapy for Retinal Pathology: Age-Related Macular Degeneration and Central Chorioretinal Dystrophy
Received: 2026-10-08
Published: 2026-06-29
Abstract
Background. The role of subthreshold micropulse laser therapy (SMLT) in age-related macular degeneration (AMD) requires critical appraisal. Central chorioretinal dystrophy is considered here in the context of age-related macular degeneration.
Objective. To evaluate the biological rationale, clinical findings and limitations of SMLT in AMD. Materials and methods. A targeted narrative review of ten publications from 2015–2025 was conducted. Experimental and clinical findings were synthesized descriptively without meta-analysis; micropulse and nanosecond technologies were distinguished.
Results. Experimental studies support activation of cellular stress responses. In a pilot study, the assessed pattern electroretinogram measure improved in 139 of 158 eyes, whereas Snellen visual acuity did not significantly change. Observational studies reported associations with reduced neovascular conversion and slower geographic atrophy enlargement. Their designs limit causal interpretation. Stable visual acuity in eyes with drusenoid pigment epithelial detachment did not exclude progression to late disease.
Discussion. Functional responses and anatomical changes cannot be equated with proven prevention of visual loss.
Conclusion. SMLT remains an investigational approach for nonexudative AMD. Controlled studies with clinically meaningful long-term outcomes are needed to define its role.
Keywords
List of references
-
Vemulakonda GA, Bailey ST, Kim SJ, Kovach JL, Lim JI, Ying GS, et al. Age-related macular degeneration Preferred Practice Pattern®. Ophthalmology. 2025;132(4):P1–P74. https://doi.org/10.1016/j.ophtha.2024.12.018.
-
Inagaki K, Shuo T, Katakura K, Ebihara N, Murakami A, Ohkoshi K. Sublethal photothermal stimulation with a micropulse laser induces heat shock protein expression in ARPE-19 cells. J Ophthalmol. 2015;2015:729792. https://doi.org/10.1155/2015/729792.
-
Wang J, Quan Y, Dalal R, Palanker D. Comparison of continuous-wave and micropulse modulation in retinal laser therapy. Invest Ophthalmol Vis Sci. 2017;58(11):4722–4732. https://doi.org/10.1167/iovs.17-21610.
-
Luttrull JK, Margolis BWL. Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: a pilot study. Invest Ophthalmol Vis Sci. 2016;57(1):265–275. https://doi.org/10.1167/iovs.15-18163.
-
Luttrull JK, Gray G. Real world data comparison of standard care vs SDM laser vision protection therapy for prevention of neovascular AMD. Clin Ophthalmol. 2022;16:1555–1568. https://doi.org/10.2147/OPTH. S366150.
-
Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, et al. Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial. Ophthalmology. 2019;126(6):829–838. https://doi.org/10.1016/j.ophtha.2018.09.015.
-
Guymer RH, Blair JPM, De Zanet S, Apostolopoulos S, Ciller C, Wu Z; LEAD Study Group. Effect of subthreshold nanosecond laser on loss of OCT outer retinal bands in age-related macular degeneration: a LEAD study report. Ophthalmol Sci. 2025;5(6):100839. https://doi.org/10.1016/j.xops.2025.100839.
-
Luttrull JK, Sinclair SH, Elmann S, Chang DB, Kent D. Slowed progression of age-related geographic atrophy following subthreshold laser. Clin Ophthalmol. 2020;14:2983–2993. https://doi.org/10.2147/OPTH. S268322.
-
Huang Z, Deng KY, Deng YM, Hui YN, Song YP. Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study. Int J Ophthalmol. 2022;15(3):474–482. https://doi.org/10.18240/ijo.2022.03.16.
-
Агзамова СС, Хикматов МН. Сравнительная оценка электрофизиологических параметров глаза у пациентов с травматической оптической нейропатией в зависимости от срока давности заболевания. Офтальмология. Восточная Европа. 2023;13(3):270–276. https://doi.org/10.34883/PI.2023.13.3.017.
About the Authors
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
